| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.5 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |